16-15407834-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000396385.4(MPV17L):āc.392T>Gā(p.Met131Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000155 in 1,612,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000092 ( 0 hom., cov: 32)
Exomes š: 0.0000075 ( 0 hom. )
Consequence
MPV17L
ENST00000396385.4 missense
ENST00000396385.4 missense
Scores
7
9
Clinical Significance
Conservation
PhyloP100: 4.94
Genes affected
MPV17L (HGNC:26827): (MPV17 mitochondrial inner membrane protein like) Involved in negative regulation of hydrogen peroxide biosynthetic process; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; and reactive oxygen species metabolic process. Located in peroxisome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16087362).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPV17L | NM_001128423.2 | c.392T>G | p.Met131Arg | missense_variant | 3/4 | ENST00000396385.4 | NP_001121895.1 | |
MPV17L | NM_173803.4 | c.321T>G | p.Asp107Glu | missense_variant | 2/3 | NP_776164.2 | ||
MPV17L-BMERB1 | NM_001414674.1 | c.310+11627T>G | intron_variant | NP_001401603.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPV17L | ENST00000396385.4 | c.392T>G | p.Met131Arg | missense_variant | 3/4 | 1 | NM_001128423.2 | ENSP00000379669.3 | ||
ENSG00000261130 | ENST00000568766.1 | c.310+11627T>G | intron_variant | 2 | ENSP00000454340.1 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151762Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
151762
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250622Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135432
GnomAD3 exomes
AF:
AC:
7
AN:
250622
Hom.:
AF XY:
AC XY:
2
AN XY:
135432
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460902Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 726732
GnomAD4 exome
AF:
AC:
11
AN:
1460902
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
726732
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151762Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74080
GnomAD4 genome
AF:
AC:
14
AN:
151762
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74080
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2024 | The c.392T>G (p.M131R) alteration is located in exon 3 (coding exon 3) of the MPV17L gene. This alteration results from a T to G substitution at nucleotide position 392, causing the methionine (M) at amino acid position 131 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationTaster
Benign
D;N
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Loss of catalytic residue at A110 (P = 0.3156);
MVP
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at